metformin has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vara-Ciruelos, D | 1 |
Dandapani, M | 1 |
Russell, FM | 1 |
Grzes, KM | 1 |
Atrih, A | 1 |
Foretz, M | 1 |
Viollet, B | 1 |
Lamont, DJ | 1 |
Cantrell, DA | 1 |
Hardie, DG | 1 |
Grimaldi, C | 1 |
Chiarini, F | 1 |
Tabellini, G | 1 |
Ricci, F | 1 |
Tazzari, PL | 1 |
Battistelli, M | 1 |
Falcieri, E | 1 |
Bortul, R | 1 |
Melchionda, F | 1 |
Iacobucci, I | 1 |
Pagliaro, P | 1 |
Martinelli, G | 1 |
Pession, A | 1 |
Barata, JT | 1 |
McCubrey, JA | 1 |
Martelli, AM | 1 |
2 other studies available for metformin and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Disease Models, An | 2019 |
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
Topics: Adenylate Kinase; Apoptosis; Base Sequence; Cell Line, Tumor; DNA Primers; Flow Cytometry; Humans; M | 2012 |